Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Parkinson's Disease

Free Subscription Articles published in Neurobiol Dis Retrieve available abstracts of 165 articles: HTML format

Single Articles

September 2026
1. DONG L, Yan Y, Wang S, Wang Z, et al
   Adaptations of the limbic system and corpus callosum white matter in early-stage PD with RBD.
   Neurobiol Dis. 2026;227:107510.
   PubMed     Abstract available
   
   
   
2. BARTALIS AE, Genschmar J, Fitzgerald JC, Hermann A, et al
   Miro1 mutations disrupt cellular calcium homeostasis via dysregulation of mitochondria-ER-contact-sites, rendering iPSC-derived neurons more susceptible to lipid peroxidation.
   Neurobiol Dis. 2026;227:107492.
   PubMed     Abstract available
   
   
   July 2026
3. HUANG CY, Chen LC, Wu RM, Hwang IS, et al
   Dual-tasking reveals severity-dependent reorganization of cortical beta energy landscapes in Parkinson's disease.
   Neurobiol Dis. 2026 Jul 16:107536. doi: 10.1016/j.nbd.2026.107536.
   PubMed     Abstract available
   
   
   
4. LIU S, Chen W, Chen X, Cai Y, et al
   Iron dyshomeostasis and enhanced myelination in the prefrontal cortex and ventral basal ganglia of a DJ-1 knockout model of early-onset Parkinson's disease.
   Neurobiol Dis. 2026 Jul 7:107519. doi: 10.1016/j.nbd.2026.107519.
   PubMed     Abstract available
   
   
   June 2026
5. BERNARD K, Corenblum MJ, Tonino P, Madhavan L, et al
   Corrigendum to "Bioenergetic And Protein Processing Imbalances in iPSC-Dopamine Neurons from Individuals with Idiopathic Parkinson's Disease" [Neurobiology of Disease 218 (2026) Epub/107222].
   Neurobiol Dis. 2026 Jun 25:107504. doi: 10.1016/j.nbd.2026.107504.
   PubMed    
   
   
   
6. DEL CID-PELLITERO E, Goiran T, Al-Azzawi ZAM, Karpilovsky NC, et al
   N-terminal acetylation reduces synuclein pathology in models of Parkinson's disease.
   Neurobiol Dis. 2026 Jun 11:107485. doi: 10.1016/j.nbd.2026.107485.
   PubMed     Abstract available
   
   
   
7. LOPEZ-AGUIRRE M, Matarazzo M, Martinez-Labrador M, Monje MHG, et al
   MRI mapping of nigrostriatal pathway degeneration in early-stage Parkinson's disease.
   Neurobiol Dis. 2026 Jun 10:107479. doi: 10.1016/j.nbd.2026.107479.
   PubMed     Abstract available
   
   
   
8. STAM MJ, van Wijk BCM, de Neeling MGJ, Keulen BJ, et al
   Shared and symptom-specific local field potential spectral signatures of motor symptoms in Parkinson's disease.
   Neurobiol Dis. 2026 Jun 5:107472. doi: 10.1016/j.nbd.2026.107472.
   PubMed     Abstract available
   
   
   May 2026
9. QIANG Q, Skudder-Hill L, Toyota T, Huang Z, et al
   Combination of CSF alpha-synuclein seed amplification assay and amyloid-beta42 predicts cognitive decline in Parkinson's disease.
   Neurobiol Dis. 2026;225:107452.
   PubMed     Abstract available
   
   
   
10. RONG S, Yang R, Li Z, Cui X, et al
    Differential cholinergic white matter microstructural alterations in multiple system atrophy and Parkinson's disease.
    Neurobiol Dis. 2026 May 12:107449. doi: 10.1016/j.nbd.2026.107449.
    PubMed     Abstract available
    
    
    
11. HANI M, Mahmoudi S, Benjelloun M
    Decoding Parkinson's progression: A multi-modal SuStaIn ensemble approach validated on real-world PPMI data.
    Neurobiol Dis. 2026 May 11:107435. doi: 10.1016/j.nbd.2026.107435.
    PubMed     Abstract available
    
    
    
12. SICILIANO M, De Micco R, Pirozzi MA, Goldman JG, et al
    From mild cognitive impairment to normal cognition in Parkinson's disease: The role of brain network architecture.
    Neurobiol Dis. 2026;225:107438.
    PubMed     Abstract available
    
    
    
13. SERPA RO, Tufano E, Connor JR
    Reimagining the contribution of iron in Parkinson's disease.
    Neurobiol Dis. 2026 May 5:107434. doi: 10.1016/j.nbd.2026.107434.
    PubMed     Abstract available
    
    
    April 2026
14. JIN H, Meng L, Yulug B, Altay O, et al
    Machine learning based multi-omics analysis reveals key molecular determinants of Parkinson's disease severity.
    Neurobiol Dis. 2026;225:107424.
    PubMed     Abstract available
    
    
    
15. TESHOME S, Torok J, Mezias C, Gupta A, et al
    Selective vulnerability of monoaminergic neurons and network spread of alpha-synuclein jointly explain pathology progression in Parkinson's disease models.
    Neurobiol Dis. 2026 Apr 27:107403. doi: 10.1016/j.nbd.2026.107403.
    PubMed     Abstract available
    
    
    
16. WEN C, Xing Y, Zhou H, Li J, et al
    Cognitive trajectories in early Parkinson's disease: A multimodal MRI study of brain structure and cognitive decline.
    Neurobiol Dis. 2026 Apr 27:107407. doi: 10.1016/j.nbd.2026.107407.
    PubMed     Abstract available
    
    
    
17. HUIN V, Cailliau E, Poupelin C, Garcon G, et al
    Blood-based biomarkers of ferroptosis in Parkinson's disease.
    Neurobiol Dis. 2026 Apr 24:107414. doi: 10.1016/j.nbd.2026.107414.
    PubMed     Abstract available
    
    
    
18. YAN WJ, Yang YL, Yan W, Tian SY, et al
    Histamine H4 receptor in neuroinflammation: Dual roles in multiple sclerosis and Parkinson's disease.
    Neurobiol Dis. 2026 Apr 15:107400. doi: 10.1016/j.nbd.2026.107400.
    PubMed     Abstract available
    
    
    
19. MEIJER L, Lindberg MF, Hogrel G, Khor B, et al
    DYRK1A and Parkinson's disease, facts and hypotheses.
    Neurobiol Dis. 2026 Apr 14:107379. doi: 10.1016/j.nbd.2026.107379.
    PubMed     Abstract available
    
    
    
20. LOMBARDI G, Fiorillo L, Castelnovo A, Bertaina I, et al
    Dynamics of slow wave sleep in advanced Parkinson's disease: An entropy-based study.
    Neurobiol Dis. 2026 Apr 13:107395. doi: 10.1016/j.nbd.2026.107395.
    PubMed     Abstract available
    
    
    
21. D'ADDARIO SL, Cenere MM, Cossa F, Scaricamazza S, et al
    Effects of neuromelanin buildup in rodent nigral dopamine neurons: implications for sex-biased vulnerability in Parkinson's disease.
    Neurobiol Dis. 2026;223:107378.
    PubMed     Abstract available
    
    
    March 2026
22. HE Y, Kaya I, Zhang X, Nilsson A, et al
    Spatial lipidomics identifies alpha-synuclein-induced lipid changes in an AAV-induced Parkinsonian mouse model.
    Neurobiol Dis. 2026;223:107372.
    PubMed     Abstract available
    
    
    
23. MOORE J, Rao L, Garcia-Bellido S, Guo F, et al
    Integration of cross-species multi-omics with in vivo experimental validation identifies Parkinson's disease therapeutic targets and novel risk factors within endolysosomal pathway subnetworks.
    Neurobiol Dis. 2026;222:107364.
    PubMed     Abstract available
    
    
    
24. CHEN K, Ji Y, Zhang R, Lu L, et al
    Linking subjective cognitive decline to glymphatic dysfunction in Parkinson's disease.
    Neurobiol Dis. 2026;221:107344.
    PubMed     Abstract available
    
    
    February 2026
25. CHENG B, Cheng S, Wei W, Pan C, et al
    Residential green space, natural environment, domestic garden, and the risk of Parkinson's disease: A prospective cohort study.
    Neurobiol Dis. 2026 Feb 25:107334. doi: 10.1016/j.nbd.2026.107334.
    PubMed     Abstract available
    
    
    
26. LIU J, Yu D, Liu Y, Yong Y, et al
    Cholinergic neurotransmission underlying visual hallucinations in Parkinson's disease: Integration of multimodal evidence and translational approaches.
    Neurobiol Dis. 2026;220:107316.
    PubMed     Abstract available
    
    
    
27. ZHENG Q, Lin X, Fei G, Xiao L, et al
    A neuropeptide receptor-enriched transcriptional state characterizes resilient dopaminergic neurons in Parkinson's disease.
    Neurobiol Dis. 2026;220:107303.
    PubMed     Abstract available
    
    
    
28. ATHIENITI E, Afxenti S, Minadakis G, Spyrou GM, et al
    Multi-omics dissection of Parkinson's patients in subgroups associated with motor and cognitive severity.
    Neurobiol Dis. 2026 Feb 2:107288. doi: 10.1016/j.nbd.2026.107288.
    PubMed     Abstract available
    
    
    
29. ROTH LM, Morozova O, Stohr J, Schapansky J, et al
    Astrocytic lysosome deficits reduce alpha-synuclein degradation and induce the spread of pathology.
    Neurobiol Dis. 2026;219:107277.
    PubMed     Abstract available
    
    
    January 2026
30. CUI J, Zhao D, Liu J, Qian J, et al
    Inhibition of the LHb glutamatergic pathway ameliorates depressive-like behaviors in a 6-hydroxydopamine-induced Parkinson's disease mouse model.
    Neurobiol Dis. 2026;220:107293.
    PubMed     Abstract available
    
    
    
31. FENG Y, Zhang W, Zhang D, Xu Y, et al
    Cerebellar contributions to cognitive deterioration in Parkinson's disease: Insights from multi-omics and longitudinal data.
    Neurobiol Dis. 2026 Jan 14:107275. doi: 10.1016/j.nbd.2026.107275.
    PubMed     Abstract available
    
    
    
32. MARANO M, Zizzo C, Cavallieri F, Avenali M, et al
    Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease.
    Neurobiol Dis. 2026 Jan 13:107271. doi: 10.1016/j.nbd.2026.107271.
    PubMed     Abstract available
    
    
    
33. BOONSTRA J, Michielse S, Temel Y, Jahanshahi A, et al
    Ultra-high-field (9.4 T) ex vivo diffusion MRI tractography reveals microstructural differences in Parkinson's disease motor subtypes.
    Neurobiol Dis. 2026;219:107266.
    PubMed     Abstract available
    
    
    December 2025
34. BALLOTTO L, Baratta T, Winterberg H, Dusanter C, et al
    Nuclear ASC speck formation in microglia is associated with inflammasome priming and is exacerbated in LRRK2-G2019S Parkinson's disease.
    Neurobiol Dis. 2025 Dec 25:107237. doi: 10.1016/j.nbd.2025.107237.
    PubMed     Abstract available
    
    
    
35. WANG M, Li Y, Yao J, Zhao W, et al
    Memory-guided saccade latency as a potential biomarker for axial symptoms and freezing of gait in Parkinson's disease.
    Neurobiol Dis. 2025 Dec 22:107238. doi: 10.1016/j.nbd.2025.107238.
    PubMed     Abstract available
    
    
    
36. REZA A, Yanagisawa T, Tani N, Fukuma R, et al
    Wirelessly transmitted subthalamic nucleus signals decode endogenous pain levels in Parkinson's disease patients.
    Neurobiol Dis. 2025 Dec 22:107235. doi: 10.1016/j.nbd.2025.107235.
    PubMed     Abstract available
    
    
    
37. RUAN X, Huang X, Wang M, Zhou Q, et al
    Network-wide morphometric organization deficits and transcriptomic correlates in Parkinson's disease with freezing of gait: A morphometric inverse divergence study.
    Neurobiol Dis. 2025 Dec 18:107230. doi: 10.1016/j.nbd.2025.107230.
    PubMed     Abstract available
    
    
    
38. BERNARD K, Corenblum MJ, Tonino P, Madhavan L, et al
    Bioenergetic and protein processing imbalances in iPSC-dopamine neurons from individuals with idiopathic Parkinson's disease.
    Neurobiol Dis. 2025 Dec 12:107222. doi: 10.1016/j.nbd.2025.107222.
    PubMed     Abstract available
    
    
    
39. HAWA Z, Mirpour K, Choi JW, Pouratian N, et al
    Beta burst characteristics predict instantaneous hand movements in Parkinson's disease.
    Neurobiol Dis. 2025;217:107157.
    PubMed     Abstract available
    
    
    November 2025
40. YIN P, Guan C, Niu X, Yang L, et al
    Corneal nerve loss measured by corneal confocal microscopy predicts pain severity in Parkinson's disease.
    Neurobiol Dis. 2025;217:107197.
    PubMed     Abstract available
    
    
    
41. DELIGANI RJ, Opri E, Risk BB, Goldstein F, et al
    Cortical beta power modulation is asymmetric and reduced during movement execution and inhibition in Parkinson's disease.
    Neurobiol Dis. 2025;217:107195.
    PubMed     Abstract available
    
    
    
42. AUNG KZ, Zin SS, Wu X, Myint ZW, et al
    Disentangling the inverse relationship between cancer and Alzheimer's or Parkinson's disease: A systematic review on Mendelian randomization studies.
    Neurobiol Dis. 2025;217:107190.
    PubMed     Abstract available
    
    
    
43. PARRELLA E, Gennari MM, Abate G, Pucci M, et al
    Early alpha-synuclein accumulation, oxidative stress and inflammation in the proximal colon of c-rel(-/-) mouse model of Parkinson's disease.
    Neurobiol Dis. 2025 Nov 7:107182. doi: 10.1016/j.nbd.2025.107182.
    PubMed     Abstract available
    
    
    
44. NACIRI LC, Melis M, Sollai G, Deligia S, et al
    A multi-dimensional study on taste deficits, alpha-synuclein genetic profiling, and supervised learning for diagnosis and disease severity stratification in Parkinson's disease (PD).
    Neurobiol Dis. 2025 Nov 3:107172. doi: 10.1016/j.nbd.2025.107172.
    PubMed     Abstract available
    
    
    October 2025
45. MIZUTANI Y, Nawashiro K, Ito S, Nakai T, et al
    Elevated TFEB expression with limited activation in peripheral blood mononuclear cells reflects altered lysosomal enzyme dynamics in Parkinson's disease.
    Neurobiol Dis. 2025;217:107151.
    PubMed     Abstract available
    
    
    
46. NUZZO T, Carrillo F, Serra M, Gentile C, et al
    Deep brain stimulation rescues the homeostasis disruption of circulating D- and L-amino acids level in men with Parkinson's disease.
    Neurobiol Dis. 2025 Oct 18:107150. doi: 10.1016/j.nbd.2025.107150.
    PubMed     Abstract available
    
    
    
47. YAN L, Ren J, Zhou H, Xing Y, et al
    Characterizing the distinct neuroanatomical phenotypes, cognitive profiles, and transcriptomic signatures of brain structural subtypes in Parkinson's disease with mild cognitive impairment.
    Neurobiol Dis. 2025 Oct 14:107141. doi: 10.1016/j.nbd.2025.107141.
    PubMed     Abstract available
    
    
    September 2025
48. RODICHKIN AN, Brown AM, Devabathini P, McGlothan JL, et al
    Cerebellar dysfunction in a mouse model of childhood-onset manganese-induced dystonia parkinsonism.
    Neurobiol Dis. 2025;216:107115.
    PubMed     Abstract available
    
    
    
49. LI P, Zhou X, Luo N, Zhou S, et al
    Dynamic cortical inhibition imbalance as a biomarker of clinical progression in early Parkinson's disease.
    Neurobiol Dis. 2025 Sep 3:107083. doi: 10.1016/j.nbd.2025.107083.
    PubMed     Abstract available
    
    
    
50. DUBACH L, Averna A, Alva L, Debove I, et al
    Unconsciousness reshapes the oscillatory topography of the subthalamic nucleus: A comparative study.
    Neurobiol Dis. 2025;213:107009.
    PubMed     Abstract available
    
    
    August 2025
51. BHARTI E, DeNicola AL, Yu Y, Verma AK, et al
    Alterations in beta oscillatory activity occur with the emergence of parkinsonian motor signs across the basal ganglia-thalamocortical network.
    Neurobiol Dis. 2025;215:107075.
    PubMed     Abstract available
    
    
    
52. CHEN T, Gong T, Chen Y, Yang A, et al
    Multimodal MRI biomarkers optimize differentiation between progressive supranuclear palsy and Parkinson's disease.
    Neurobiol Dis. 2025;215:107076.
    PubMed     Abstract available
    
    
    
53. GRILLO P, Di Martino D, Calculli A, De Icco R, et al
    Physical exercise modulates plasma irisin levels in endurance athletes: Implications for Parkinson's disease.
    Neurobiol Dis. 2025 Aug 23:107065. doi: 10.1016/j.nbd.2025.107065.
    PubMed     Abstract available
    
    
    
54. LUCAS-DEL-POZO S, Uras G, Fierli F, Lentini V, et al
    Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson's disease cell models.
    Neurobiol Dis. 2025 Aug 12:107053. doi: 10.1016/j.nbd.2025.107053.
    PubMed     Abstract available
    
    
    
55. BROWN HJ, Fan RZ, Bell R, Salehe SS, et al
    Imbalanced mitochondrial dynamics in human PD and alpha-synuclein mouse brains.
    Neurobiol Dis. 2025;212:106976.
    PubMed     Abstract available
    
    
    June 2025
56. ZHI Y, Chen K, You Y, Ji Y, et al
    Hypo-connected pattern in Parkinson's disease with pure apathy: A dynamic functional connectivity perspective.
    Neurobiol Dis. 2025;213:107008.
    PubMed     Abstract available
    
    
    
57. ZHU Z, Duanmu X, Zhou C, Wen J, et al
    Glymphatic dysfunction is related to motor disability fully mediated by gray matter degeneration in early-stage Parkinson's disease.
    Neurobiol Dis. 2025;213:107001.
    PubMed     Abstract available
    
    
    
58. CARRILLO F, Palomba NP, Pietracupa S, Ianiro L, et al
    ANKK1, ANKRD50, GRK5, PACSIN1 and VPS8 are novel candidate genes associated with late onset Parkinson's disease: Definition of a novel predictive protocol based on polygenic model of inheritance.
    Neurobiol Dis. 2025;213:106996.
    PubMed     Abstract available
    
    
    
59. SUN J, Chen L, Li L, Wu T, et al
    Less locus coeruleus degeneration and its enhanced influence on neural circuit in Parkinson's tremor.
    Neurobiol Dis. 2025 Jun 3:106960. doi: 10.1016/j.nbd.2025.106960.
    PubMed     Abstract available
    
    
    
60. YIN X, Wang M, Zhao F, Li F, et al
    Choroid plexus area and choroid plexus /lateral ventricle area index are potential imaging markers for freezing of gait in Parkinson's disease.
    Neurobiol Dis. 2025 Jun 2:106984. doi: 10.1016/j.nbd.2025.106984.
    PubMed     Abstract available
    
    
    May 2025
61. FALLETTI M, Asci F, Zampogna A, Patera M, et al
    Cogwheel rigidity in Parkinson's disease: Clinical, biomechanical and neurophysiological features.
    Neurobiol Dis. 2025;212:106980.
    PubMed     Abstract available
    
    
    
62. PARK G, Ha J, Lee JS, Ahn JH, et al
    Data-driven, cross-sectional image-based subtyping and staging of brain volumetric changes in Parkinson's disease.
    Neurobiol Dis. 2025;212:106970.
    PubMed     Abstract available
    
    
    
63. CVL D, Munro J, Berard M, Di Paolo T, et al
    Serotonin innervation of the subthalamic nucleus in parkinsonian monkeys.
    Neurobiol Dis. 2025 May 2:106938. doi: 10.1016/j.nbd.2025.106938.
    PubMed     Abstract available
    
    
    April 2025
64. MENG L, Wang D, Ma J, Shi Y, et al
    Unraveling Parkinson's disease motor subtypes: A deep learning approach based on spatiotemporal dynamics of EEG microstates.
    Neurobiol Dis. 2025 Apr 22:106915. doi: 10.1016/j.nbd.2025.106915.
    PubMed     Abstract available
    
    
    
65. XUE G, Wang G, Shi Q, Wang H, et al
    Exploring the dynamic pathogenesis of Parkinson's disease by case-control and longitudinal blood transcriptome analyses.
    Neurobiol Dis. 2025;209:106891.
    PubMed     Abstract available
    
    
    
66. WEN S, Li Y, Xiang W, Shen F, et al
    A novel mouse model of chronic neuronopathic Gaucher disease exhibits Parkinson's disease-like phenotypes.
    Neurobiol Dis. 2025;209:106899.
    PubMed     Abstract available
    
    
    March 2025
67. MINGO YB, Escobar Galvis ML, Henderson MX
    alpha-Synuclein pathology and mitochondrial dysfunction: Toxic partners in Parkinson's disease.
    Neurobiol Dis. 2025;209:106889.
    PubMed     Abstract available
    
    
    
68. YUAN YT, Hong WP, Tan CH, Yu RL, et al
    Influence of WWOX/MAF genes on cognitive performance in patients with Parkinson's disease.
    Neurobiol Dis. 2025;208:106887.
    PubMed     Abstract available
    
    
    
69. BUONOCORE A, Cafaro C, De Luca C, Vermiglio G, et al
    Lack of pre-movement facilitation as neurophysiological hallmark of fatigue in patients with Parkinson's disease: A single pulse TMS study.
    Neurobiol Dis. 2025;208:106878.
    PubMed     Abstract available
    
    
    
70. LINAN VS, Rioux V, Peralta M 3rd, Dupre N, et al
    Early detection of Parkinson's disease: Retinal functional impairments as potential biomarkers.
    Neurobiol Dis. 2025 Mar 14:106872. doi: 10.1016/j.nbd.2025.106872.
    PubMed     Abstract available
    
    
    
71. SUN H, Gan C, Cao X, Yuan Y, et al
    Microstructural and functional abnormalities of the locus coeruleus in freezing of gait in Parkinson's disease.
    Neurobiol Dis. 2025 Mar 9:106868. doi: 10.1016/j.nbd.2025.106868.
    PubMed     Abstract available
    
    
    
72. WANG B, Gannon M, Pattanayak R, Scholz K, et al
    14-3-3theta phosphorylation exacerbates alpha-synuclein aggregation and toxicity.
    Neurobiol Dis. 2025;206:106801.
    PubMed     Abstract available
    
    
    February 2025
73. WICHMANN T, Nelson A, Torres ERS, Svenningsson P, et al
    Leveraging animal models to understand non-motor symptoms of Parkinson's disease.
    Neurobiol Dis. 2025 Feb 27:106848. doi: 10.1016/j.nbd.2025.106848.
    PubMed     Abstract available
    
    
    
74. FREDLUND F, Fryklund C, Trujeque-Ramos O, Staley HA, et al
    Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-alpha-Syn?+?PFFs-induced rat model for Parkinson's disease.
    Neurobiol Dis. 2025 Feb 13:106841. doi: 10.1016/j.nbd.2025.106841.
    PubMed     Abstract available
    
    
    
75. DIAO Y, Yin Z, Zhao B, Xu Y, et al
    Abnormal neuronal activity in the subthalamic nucleus contributes to dysarthria in patients with Parkinson's disease.
    Neurobiol Dis. 2025 Feb 3:106830. doi: 10.1016/j.nbd.2025.106830.
    PubMed     Abstract available
    
    
    
76. HARTKE AS, Schreiber CS, Lau K, Wiesweg I, et al
    Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins.
    Neurobiol Dis. 2025;205:106773.
    PubMed     Abstract available
    
    
    January 2025
77. GUO T, Zhou C, Wen J, Wu J, et al
    Aberrant functional connectome gradient and its neurotransmitter basis in Parkinson's disease.
    Neurobiol Dis. 2025;206:106821.
    PubMed     Abstract available
    
    
    
78. DEL PERCIO C, Lizio R, Lopez S, Noce G, et al
    Resting-state electroencephalographic rhythms depend on sex in patients with dementia due to Parkinson's and Lewy Body diseases: An exploratory study.
    Neurobiol Dis. 2025;206:106807.
    PubMed     Abstract available
    
    
    
79. BOLEN ML, Gomes BN, Gill B, Menees KB, et al
    Peripheral blood immune cells from individuals with Parkinson's disease or inflammatory bowel disease share deficits in iron storage and transport that are modulated by non-steroidal anti-inflammatory drugs.
    Neurobiol Dis. 2025 Jan 11:106794. doi: 10.1016/j.nbd.2025.106794.
    PubMed     Abstract available
    
    
    December 2024
80. HUANG CW, Tsai HY, Lin YH, Lin WW, et al
    Striatal-cortical dysconnectivity underlies somatosensory deficits in Parkinson's disease: Insights from rhythmic auditory-motor training.
    Neurobiol Dis. 2024 Dec 22:106778. doi: 10.1016/j.nbd.2024.106778.
    PubMed     Abstract available
    
    
    October 2024
81. LAI MS, Sorensen MH, Lee K, Chu JM, et al
    3D mapping of direct VTA-CA2 circuit with potential involvement in Parkinson's disease degeneration.
    Neurobiol Dis. 2024;202:106723.
    PubMed     Abstract available
    
    
    
82. CARRILLO F, Palomba NP, Ghirimoldi M, Dido C, et al
    Multiomics approach discloses lipids and metabolites profiles associated to Parkinson's disease stages and applied therapies.
    Neurobiol Dis. 2024 Oct 18:106698. doi: 10.1016/j.nbd.2024.106698.
    PubMed     Abstract available
    
    
    
83. CAO C, Litvak V, Zhan S, Liu W, et al
    Low-beta versus high-beta band cortico-subcortical coherence in movement inhibition and expectation.
    Neurobiol Dis. 2024;201:106689.
    PubMed     Abstract available
    
    
    
84. MASSARI CM, Dues DJ, Bergsma A, Sipple K, et al
    Neuropathology in an alpha-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein.
    Neurobiol Dis. 2024;202:106701.
    PubMed     Abstract available
    
    
    
85. MENDONCA MD, Ferreira P, Barbosa R, da Silva JA, et al
    Brain-first forms of Parkinson's disease are over-represented in patients with non-responsive resting tremor.
    Neurobiol Dis. 2024;201:106691.
    PubMed     Abstract available
    
    
    
86. CHEN B, Zhou H, Liu X, Yang W, et al
    Correlations of gray matter volume with peripheral cytokines in Parkinson's disease.
    Neurobiol Dis. 2024 Oct 3:106693. doi: 10.1016/j.nbd.2024.106693.
    PubMed     Abstract available
    
    
    September 2024
87. LIU J, Ji Z, He Q, Chen H, et al
    Direct conversion of human umbilical cord mesenchymal stem cells into dopaminergic neurons for Parkinson's disease treatment.
    Neurobiol Dis. 2024;201:106683.
    PubMed     Abstract available
    
    
    
88. SHEN B, Yao Q, Li W, Dong S, et al
    Dynamic cerebellar and sensorimotor network compensation in tremor-dominated Parkinson's disease.
    Neurobiol Dis. 2024;201:106659.
    PubMed     Abstract available
    
    
    
89. SERMON JJ, Wiest C, Tan H, Denison T, et al
    Evoked resonant neural activity long-term dynamics can be reproduced by a computational model with vesicle depletion.
    Neurobiol Dis. 2024;199:106565.
    PubMed     Abstract available
    
    
    August 2024
90. PARK DG, Kang W, Shin IJ, Chalita M, et al
    Difference in gut microbial dysbiotic patterns between body-first and brain-first Parkinson's disease.
    Neurobiol Dis. 2024;201:106655.
    PubMed     Abstract available
    
    
    
91. GRENNAN I, Mallet N, Magill PJ, Cagnan H, et al
    Beta bursts in the parkinsonian cortico-basal ganglia network form spatially discrete ensembles.
    Neurobiol Dis. 2024 Aug 27:106652. doi: 10.1016/j.nbd.2024.106652.
    PubMed     Abstract available
    
    
    
92. STETZIK L, Mercado G, Steiner JA, Lindquist A, et al
    Heterozygous loss of Engrailed-1 and alpha-synucleinopathy (En1/SYN): A dual-hit preclinical mouse model of Parkinson's disease, analyzed with artificial intelligence.
    Neurobiol Dis. 2024 Aug 24:106647. doi: 10.1016/j.nbd.2024.106647.
    PubMed     Abstract available
    
    
    
93. LI B, Dettmer U
    Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies.
    Neurobiol Dis. 2024 Aug 22:106646. doi: 10.1016/j.nbd.2024.106646.
    PubMed     Abstract available
    
    
    
94. MASSACCI G, Venafra V, Zwiebel M, Wahle M, et al
    Stage-dependent phosphoproteome remodeling of Parkinson's disease blood cells.
    Neurobiol Dis. 2024;200:106622.
    PubMed     Abstract available
    
    
    July 2024
95. CAMPAGNOLO M, Weis L, Sandre M, Tushevski A, et al
    Immune landscape of the enteric nervous system differentiates Parkinson's disease patients from controls: The PADUA-CESNE cohort.
    Neurobiol Dis. 2024;200:106609.
    PubMed     Abstract available
    
    
    
96. ADOM MA, Hahn WN, McCaffery TD, Moors TE, et al
    Reducing the lipase LIPE in mutant alpha-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism.
    Neurobiol Dis. 2024;199:106593.
    PubMed     Abstract available
    
    
    
97. FASANO A, Mure H, Oyama G, Murase N, et al
    Subthalamic nucleus local field potential stability in patients with Parkinson's disease.
    Neurobiol Dis. 2024;199:106589.
    PubMed     Abstract available
    
    
    June 2024
98. MESAROSOVA L, Scheper M, Iyer A, Anink JJ, et al
    miR-193b-3p/ PGC-1alpha pathway regulates an insulin dependent anti-inflammatory response in Parkinson's disease.
    Neurobiol Dis. 2024 Jun 29:106587. doi: 10.1016/j.nbd.2024.106587.
    PubMed     Abstract available
    
    
    
99. LI X, Pang H, Bu S, Zhao M, et al
    Stage-dependent differential impact of network communication on cognitive function across the continuum of cognitive decline in Parkinson's disease.
    Neurobiol Dis. 2024 Jun 24:106578. doi: 10.1016/j.nbd.2024.106578.
    PubMed     Abstract available
    
    
    
100. TEZUKA T, Ishiguro M, Taniguchi D, Osogaguchi E, et al
     Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease.
     Neurobiol Dis. 2024 Jun 18:106571. doi: 10.1016/j.nbd.2024.106571.
     PubMed     Abstract available
     
     
     
101. MASATO A, Bubacco L
     The alphaSynuclein half-life conundrum.
     Neurobiol Dis. 2024;196:106524.
     PubMed     Abstract available
     
     
     
102. GAO AYL, Montagna DR, Hirst WD, Temkin PA, et al
     RIT2 regulates autophagy lysosomal pathway induction and protects against alpha-synuclein pathology in a cellular model of Parkinson's disease.
     Neurobiol Dis. 2024;199:106568.
     PubMed     Abstract available
     
     
     
103. BAARBE J, Brown MJN, Saha U, Tran S, et al
     Cortical modulations before lower limb motor blocks are associated with freezing of gait in Parkinson's disease: an EEG source localization study.
     Neurobiol Dis. 2024 Jun 7:106557. doi: 10.1016/j.nbd.2024.106557.
     PubMed     Abstract available
     
     
     
104. GAN C, Cao X, Sun H, Ye S, et al
     Multimodal neuroimaging fusion unravel structural-functional-neurotransmitter change in Parkinson's disease with impulse control disorders.
     Neurobiol Dis. 2024;198:106560.
     PubMed     Abstract available
     
     
     
105. LEAVITT D, Alanazi FI, Al-Ozzi TM, Cohn M, et al
     Auditory oddball responses in the human subthalamic nucleus and substantia nigra pars reticulata.
     Neurobiol Dis. 2024;195:106490.
     PubMed     Abstract available
     
     
     
106. YAN S, Lu J, Duan B, Zhu H, et al
     Quantitative susceptibility mapping of multiple system atrophy and Parkinson's disease correlates with neurotransmitter reference maps.
     Neurobiol Dis. 2024;198:106549.
     PubMed     Abstract available
     
     
     May 2024
107. CASANOVA F, Tian Q, Williamson DS, Qian Y, et al
     MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: Observational and genetic analysis in the UK Biobank cohort.
     Neurobiol Dis. 2024 May 22:106539. doi: 10.1016/j.nbd.2024.106539.
     PubMed     Abstract available
     
     
     
108. GULBERTI A, Schneider TR, Galindo-Leon EE, Heise M, et al
     Premotor cortical beta synchronization and the network neuromodulation of externally paced finger tapping in Parkinson's disease.
     Neurobiol Dis. 2024 May 11:106529. doi: 10.1016/j.nbd.2024.106529.
     PubMed     Abstract available
     
     
     
109. SHI D, Wu S, Zhuang C, Mao Y, et al
     Multimodal data fusion reveals functional and neurochemical correlates of Parkinson's disease.
     Neurobiol Dis. 2024 May 11:106527. doi: 10.1016/j.nbd.2024.106527.
     PubMed     Abstract available
     
     
     
110. ILIEVA NM, Hoffman EK, Ghalib MA, Greenamyre JT, et al
     LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants.
     Neurobiol Dis. 2024 May 3:106522. doi: 10.1016/j.nbd.2024.106522.
     PubMed     Abstract available
     
     
     
111. HEMBACH S, Schmidt S, Orschmann T, Burtscher I, et al
     Engrailed 1 deficiency induces changes in ciliogenesis during human neuronal differentiation.
     Neurobiol Dis. 2024;194:106474.
     PubMed     Abstract available
     
     
     April 2024
112. GUO X, He S, Geng X, Yao P, et al
     Quantifying local field potential dynamics with amplitude and frequency stability between ON and OFF medication and stimulation in Parkinson's disease.
     Neurobiol Dis. 2024 Apr 27:106519. doi: 10.1016/j.nbd.2024.106519.
     PubMed     Abstract available
     
     
     
113. RURAK BK, Tan J, Rodrigues JP, Power BD, et al
     Cortico-cortical connectivity is influenced by levodopa in tremor-dominant Parkinson's disease.
     Neurobiol Dis. 2024;196:106518.
     PubMed     Abstract available
     
     
     
114. TREMBLAY C, Aslam S, Walker JE, Lorenzini I, et al
     RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction.
     Neurobiol Dis. 2024 Apr 23:106514. doi: 10.1016/j.nbd.2024.106514.
     PubMed     Abstract available
     
     
     
115. BUOSO C, Seifert M, Lang M, Griffith CM, et al
     Dopamine?iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease.
     Neurobiol Dis. 2024 Apr 20:106506. doi: 10.1016/j.nbd.2024.106506.
     PubMed     Abstract available
     
     
     
116. TONG B, Ba Y, Li Z, Yang C, et al
     Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.
     Neurobiol Dis. 2024 Apr 18:106505. doi: 10.1016/j.nbd.2024.106505.
     PubMed     Abstract available
     
     
     
117. JIAO LL, Dong HL, Liu MM, Wu PL, et al
     The potential roles of salivary biomarkers in neurodegenerative diseases.
     Neurobiol Dis. 2024;193:106442.
     PubMed     Abstract available
     
     
     March 2024
118. IOVINO L, Vander Zwaag J, Kaur G, Khakpour M, et al
     Investigation of microglial diversity in a LRRK2 G2019S mouse model of Parkinson's disease.
     Neurobiol Dis. 2024 Mar 23:106481. doi: 10.1016/j.nbd.2024.106481.
     PubMed     Abstract available
     
     
     
119. ZHOU C, You J, Guan X, Guo T, et al
     Microstructural alterations of the hypothalamus in Parkinson's disease and probable REM sleep behavior disorder.
     Neurobiol Dis. 2024 Mar 11:106472. doi: 10.1016/j.nbd.2024.106472.
     PubMed     Abstract available
     
     
     February 2024
120. HUANG YT, Chen YW, Lin TY, Chen JC, et al
     Suppression of presynaptic corticostriatal glutamate activity attenuates L-dopa-induced dyskinesia in 6-OHDA-lesioned Parkinson's disease mice.
     Neurobiol Dis. 2024;193:106452.
     PubMed     Abstract available
     
     
     
121. STOLL AC, Kemp CJ, Patterson JR, Howe JW, et al
     Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions.
     Neurobiol Dis. 2024;191:106411.
     PubMed     Abstract available
     
     
     January 2024
122. IMARISIO A, Yahyavi I, Avenali M, Di Maio A, et al
     Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease.
     Neurobiol Dis. 2024;192:106413.
     PubMed     Abstract available
     
     
     
123. WU C, Wu H, Zhou C, Guan X, et al
     Neurovascular coupling alteration in drug-naive Parkinson's disease: The underlying molecular mechanisms and levodopa's restoration effects.
     Neurobiol Dis. 2024 Jan 8:106406. doi: 10.1016/j.nbd.2024.106406.
     PubMed     Abstract available
     
     
     
124. SALIN P, Melon C, Chassain C, Gubellini P, et al
     Interhemispheric reactivity of the subthalamic nucleus sustains progressive dopamine neuron loss in asymmetrical parkinsonism.
     Neurobiol Dis. 2024;191:106398.
     PubMed     Abstract available
     
     
     December 2023
125. TRAN S, Heida TC, Heijs JJA, Al-Ozzi T, et al
     Subthalamic and pallidal neurons are modulated during externally cued movements in Parkinson's disease.
     Neurobiol Dis. 2023 Dec 20:106384. doi: 10.1016/j.nbd.2023.106384.
     PubMed     Abstract available
     
     
     
126. LIANG K, Li X, Guo Q, Ma J, et al
     Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
     Neurobiol Dis. 2023;190:106379.
     PubMed     Abstract available
     
     
     
127. DI LAZZARO G, Picca A, Boldrini S, Bove F, et al
     Differential profiles of serum cytokines in Parkinson's disease according to disease duration.
     Neurobiol Dis. 2023 Dec 5:106371. doi: 10.1016/j.nbd.2023.106371.
     PubMed     Abstract available
     
     
     November 2023
128. TSHILENGE KT, Bons J, Aguirre CG, Geronimo-Olvera C, et al
     Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
     Neurobiol Dis. 2023 Nov 30:106367. doi: 10.1016/j.nbd.2023.106367.
     PubMed     Abstract available
     
     
     
129. TOFFOLI M, Chohan H, Mullin S, Jesuthasan A, et al
     Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study.
     Neurobiol Dis. 2023 Nov 3:106343. doi: 10.1016/j.nbd.2023.106343.
     PubMed     Abstract available
     
     
     
130. HARVEY J, Pishva E, Chouliaras L, Lunnon K, et al
     Elucidating distinct molecular signatures of Lewy body dementias.
     Neurobiol Dis. 2023;188:106337.
     PubMed     Abstract available
     
     
     
131. TUBERT C, Zampese E, Pancani T, Tkatch T, et al
     Feed-forward metabotropic signaling by Cav1 Ca(2+) channels supports pacemaking in pedunculopontine cholinergic neurons.
     Neurobiol Dis. 2023;188:106328.
     PubMed     Abstract available
     
     
     
132. DUES DJ, Ma Y, Nguyen APT, Offerman AV, et al
     Formation of templated inclusions in a forebrain alpha-synuclein mouse model is independent of LRRK2.
     Neurobiol Dis. 2023;188:106338.
     PubMed     Abstract available
     
     
     October 2023
133. RIVAS-SANTISTEBAN R, Rico A, Munoz A, Rodriguez AI, et al
     Boolean analysis shows a high proportion of dopamine D(2) receptors interacting with adenosine A(2A) receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease.
     Neurobiol Dis. 2023 Oct 31:106341. doi: 10.1016/j.nbd.2023.106341.
     PubMed     Abstract available
     
     
     
134. CHEN L, Sun J, Gao L, Wang J, et al
     Dysconnectivity of the parafascicular nucleus in Parkinson's disease: A dynamic causal modeling analysis.
     Neurobiol Dis. 2023;188:106335.
     PubMed     Abstract available
     
     
     
135. LAU K, Porschen LT, Richter F, Gericke B, et al
     Microvascular blood-brain barrier alterations in isolated brain capillaries of mice over-expressing alpha-synuclein (Thy1-aSyn line 61).
     Neurobiol Dis. 2023;187:106298.
     PubMed     Abstract available
     
     
     
136. LI T, Liu T, Zhang J, Ma Y, et al
     Neurovascular coupling dysfunction of visual network organization in Parkinson's disease.
     Neurobiol Dis. 2023;188:106323.
     PubMed     Abstract available
     
     
     
137. MAPLE-GRODEM J, Ushakova A, Pedersen KF, Tysnes OB, et al
     Identification of diagnostic and prognostic biomarkers of PD using a multiplex proteomics approach.
     Neurobiol Dis. 2023;186:106281.
     PubMed     Abstract available
     
     
     
138. SCHAFFNER SL, Wassouf Z, Hentrich T, Nuesch-Germano M, et al
     Distinct impacts of alpha-synuclein overexpression on the hippocampal epigenome of mice in standard and enriched environments.
     Neurobiol Dis. 2023;186:106274.
     PubMed     Abstract available
     
     
     September 2023
139. DE FABREGUES O, Selles M, Ramos-Vicente D, Roch G, et al
     Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson's disease and examination of its possible etiologies: infectious or autoimmune?
     Neurobiol Dis. 2023 Sep 21:106308. doi: 10.1016/j.nbd.2023.106308.
     PubMed     Abstract available
     
     
     
140. TRINH D, Israwi AR, Brar H, Villafuerte JEA, et al
     Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy.
     Neurobiol Dis. 2023 Sep 11:106287. doi: 10.1016/j.nbd.2023.106287.
     PubMed     Abstract available
     
     
     August 2023
141. GRONLIER E, Volle J, Coizet V, Paccard A, et al
     Evoked responses to single pulse electrical stimulation reveal impaired striatal excitability in a rat model of Parkinson's disease.
     Neurobiol Dis. 2023 Aug 19:106266. doi: 10.1016/j.nbd.2023.106266.
     PubMed     Abstract available
     
     
     
142. GAN C, Ji M, Sun H, Cao X, et al
     Dynamic functional connectivity reveals hyper-connected pattern and abnormal variability in freezing of gait of Parkinson's disease.
     Neurobiol Dis. 2023;185:106265.
     PubMed     Abstract available
     
     
     
143. REN J, Yan L, Zhou H, Pan C, et al
     Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease.
     Neurobiol Dis. 2023 Aug 7:106254. doi: 10.1016/j.nbd.2023.106254.
     PubMed     Abstract available
     
     
     
144. DUMONT M, Agostinis A, Singh K, Swan E, et al
     Sex representation in neurodegenerative and psychiatric disorders' preclinical and clinical studies.
     Neurobiol Dis. 2023;184:106214.
     PubMed     Abstract available
     
     
     
145. BHATIA TN, Jamenis AS, Abbas M, Clark RN, et al
     A 14-day pulse of PLX5622 modifies alpha-synucleinopathy in preformed fibril-infused aged mice of both sexes.
     Neurobiol Dis. 2023;184:106196.
     PubMed     Abstract available
     
     
     July 2023
146. CROCKETT RA, Wilkins KB, Aditham S, Bronte-Stewart HM, et al
     No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment.
     Neurobiol Dis. 2023 Jul 29:106243. doi: 10.1016/j.nbd.2023.106243.
     PubMed     Abstract available
     
     
     
147. URSO D, Batzu L, Logroscino G, Chaudhuri KR, et al
     Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease.
     Neurobiol Dis. 2023 Jul 25:106237. doi: 10.1016/j.nbd.2023.106237.
     PubMed     Abstract available
     
     
     
148. AVANTAGGIATO F, Farokhniaee A, Bandini A, Palmisano C, et al
     Intelligibility of speech in Parkinson's disease relies on anatomically segregated subthalamic beta oscillations.
     Neurobiol Dis. 2023 Jul 25:106239. doi: 10.1016/j.nbd.2023.106239.
     PubMed     Abstract available
     
     
     
149. WANG Y, Xia Y, Kou L, Yin S, et al
     Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease.
     Neurobiol Dis. 2023 Jul 9:106224. doi: 10.1016/j.nbd.2023.106224.
     PubMed     Abstract available
     
     
     
150. LEGAZ A, Prado P, Moguilner S, Baez S, et al
     Social and non-social working memory in neurodegeneration.
     Neurobiol Dis. 2023;183:106171.
     PubMed     Abstract available
     
     
     June 2023
151. WU H, Wu C, Qin J, Zhou C, et al
     Functional connectome predicting individual gait function and its relationship with molecular architecture in Parkinson's disease.
     Neurobiol Dis. 2023;184:106216.
     PubMed     Abstract available
     
     
     
152. DI MAIO A, Nuzzo T, Gilio L, Serra M, et al
     Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.
     Neurobiol Dis. 2023 Jun 17:106203. doi: 10.1016/j.nbd.2023.106203.
     PubMed     Abstract available
     
     
     
153. BATZU L, Urso D, Grothe MJ, Vereb D, et al
     Increased basal forebrain volumes could prevent cognitive decline in LRRK2 Parkinson's disease.
     Neurobiol Dis. 2023 Jun 5:106182. doi: 10.1016/j.nbd.2023.106182.
     PubMed     Abstract available
     
     
     
154. ZHONG M, Wang Y, Lin G, Liao FF, et al
     Dopamine-independent development and maintenance of mouse striatal medium spiny neuron dendritic spines.
     Neurobiol Dis. 2023;181:106096.
     PubMed     Abstract available
     
     
     May 2023
155. LUCHETTI S, Liere P, Pianos A, Verwer RWH, et al
     Disease stage-dependent changes in brain levels and neuroprotective effects of neuroactive steroids in Parkinson's disease.
     Neurobiol Dis. 2023 May 29:106169. doi: 10.1016/j.nbd.2023.106169.
     PubMed     Abstract available
     
     
     
156. YIN Z, Jiang Y, Merk T, Neumann WJ, et al
     Pallidal activities during sleep and sleep decoding in dystonia, Huntington's, and Parkinson's disease.
     Neurobiol Dis. 2023 May 3:106143. doi: 10.1016/j.nbd.2023.106143.
     PubMed     Abstract available
     
     
     
157. FAYARD A, Fenyi A, Lavisse S, Dovero S, et al
     Functional and neuropathological changes induced by injection of distinct alpha-synuclein strains: A pilot study in non-human primates.
     Neurobiol Dis. 2023;180:106086.
     PubMed     Abstract available
     
     
     
158. CHEN Z, Reynolds RH, Pardinas AF, Gagliano Taliun SA, et al
     The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases.
     Neurobiol Dis. 2023;180:106082.
     PubMed     Abstract available
     
     
     April 2023
159. GUERRA A, Colella D, Cannavacciuolo A, Giangrosso M, et al
     Short-term plasticity of the motor cortex compensates for bradykinesia in Parkinson's disease.
     Neurobiol Dis. 2023;182:106137.
     PubMed     Abstract available
     
     
     
160. HAYLEY S, Vahid-Ansari F, Sun H, Albert PR, et al
     Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models.
     Neurobiol Dis. 2023 Apr 8:106115. doi: 10.1016/j.nbd.2023.106115.
     PubMed     Abstract available
     
     
     
161. SASIKUMAR S, Sorrento G, Lang AE, Strafella AP, et al
     Cognition affects gait adaptation after split-belt treadmill training in Parkinson's disease.
     Neurobiol Dis. 2023 Apr 3:106109. doi: 10.1016/j.nbd.2023.106109.
     PubMed     Abstract available
     
     
     March 2023
162. CAULFIELD ME, Vander Werp MJ, Stancati JA, Collier TJ, et al
     Downregulation of striatal Ca(V)1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age.
     Neurobiol Dis. 2023 Mar 29:106111. doi: 10.1016/j.nbd.2023.106111.
     PubMed     Abstract available
     
     
     
163. HUANG Q, Chen C, Chen W, Cai C, et al
     Cell type- and region-specific translatomes in an MPTP mouse model of Parkinson's disease.
     Neurobiol Dis. 2023;180:106105.
     PubMed     Abstract available
     
     
     
164. TAN S, Zhou C, Wen J, Duanmu X, et al
     Presence but not the timing of onset of REM sleep behavior disorder distinguishes evolution patterns in Parkinson's disease.
     Neurobiol Dis. 2023;180:106084.
     PubMed     Abstract available
     
     
     
165. PORRINI V, Pilotto A, Vezzoli M, Lanzillotta A, et al
     NF-kappaB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients.
     Neurobiol Dis. 2023 Mar 7:106067. doi: 10.1016/j.nbd.2023.106067.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum